Side effects of COVID-19 vaccines in the middle eastern population

被引:0
|
作者
Murished, Ghida M. [1 ]
Dandachi, Iman [1 ]
Aljabr, Waleed [1 ]
机构
[1] King Fahad Med City, Res Ctr, Riyadh, Saudi Arabia
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
COVID-19; vaccines; side effects; immune response; children; high-risk population; BELLS-PALSY; SAFETY; MYOCARDITIS; RESIDENTS; SYMPTOMS; PROVINCE; CHILDREN;
D O I
10.3389/fimmu.2023.1270187
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The COVID-19 pandemic has caused severe worldwide health concerns since its first description as the SARS-COV-2 virus in December 2019. The wide dissemination of this virus, together with the lack of treatment, prompted vaccine development within a short period of time to elicit a protective immunity against COVID-19. Due to their rapid development, potential subsequent side effects of COVID-19 vaccines were overlooked, which might lead to many health concerns. This is especially true for patients at a greater risk of harm from COVID-19, such as pregnant women, children, and patients with pre-existing chronic diseases. In this review, we provide a summary of common to rare side effects of administrated COVID-19 vaccines in a Middle Eastern population. We have found that the distinction between side effects from COVID-19 vaccines in terms of frequency and severity is attributed to the differences in study populations, gender, and age. Pain at the injection site, fever, headache, fatigue, and muscle pain were the most common reported side effects. Vaccinated subjects with previous COVID-19 infection exhibited an equivalent neutralizing response after just one dose compared to two doses of vaccine. Consequently, individuals who experienced more side effects had significantly higher antibody levels. This indicates that having better immunity correlates with higher antibody levels, leading to a higher frequency of vaccine side effects. Individuals with underlying comorbidities, particularly having known allergies and with illnesses such as diabetes and cancer, might be more prone to post-vaccination side effects. Studies of a high-risk population in Middle Eastern countries are limited. Future studies should be considered to determine long-term side effects, side effects after booster doses, and side effect differences in cases of heterologous and homologous vaccination for better understanding and proper handling of high-risk populations and patients who experience these side effects.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] COVID-19: vaccines, efficacy and effects on variants
    Rudan, Igor
    Adeloye, Davies
    Sheikh, Aziz
    CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (03) : 180 - 191
  • [42] The effects of COVID-19 vaccines on economic activity
    Deb P.
    Furceri D.
    Jimenez D.
    Kothari S.
    Ostry J.D.
    Tawk N.
    Swiss Journal of Economics and Statistics, 158 (1)
  • [43] Covid19 Vaccines and the Misinterpretation of Perceived Side Effects
    Palmer, Raymond D.
    BIOMEDICINE-TAIWAN, 2022, 12 (03):
  • [44] Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects
    Hajjo, Rima
    Sabbah, Dima A.
    Tropsha, Alexander
    PATHOGENS, 2022, 11 (07):
  • [45] A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis
    Mohamed, Malik Suliman
    Mohamed, Ahmed Osman
    Alenazy, Rawaf
    Khan, Yusra Habib
    Idriss, Mona Timan
    Alhudaib, Noura A. A.
    Elsaman, Tilal
    Mohamed, Magdi Awadalla
    Eltayib, Eyman M. M.
    Mallhi, Tauqeer Hussain
    VACCINES, 2023, 11 (02)
  • [46] COVID-19 Vaccines
    不详
    US PHARMACIST, 2021, 46 (02)
  • [47] Vaccines for COVID-19
    Tregoning, J. S.
    Brown, E. S.
    Cheeseman, H. M.
    Flight, K. E.
    Higham, S. L.
    Lemm, N-M
    Pierce, B. F.
    Stirling, D. C.
    Wang, Z.
    Pollock, K. M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 202 (02): : 162 - 192
  • [48] COVID-19 vaccines
    Demirdover, Cenk
    TURKISH JOURNAL OF PLASTIC SURGERY, 2021, 29 (01) : 1 - 3
  • [49] COVID-19 Vaccines
    Hahn, William O.
    Wiley, Zanthia
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2022, 36 (02) : 481 - 494
  • [50] COVID-19 vaccines
    Ndwandwe, Duduzile
    Wiysonge, Charles S.
    CURRENT OPINION IN IMMUNOLOGY, 2021, 71 : 111 - 116